The study of sleep medicine & breathing disorders continues to uncover complex interrelations between respiratory physiology and sleep architecture. Obstructive sleep apnea, central sleep apnea, and nocturnal hypoventilation syndromes are now understood as contributors to cardiovascular disease, metabolic dysfunction, and neurocognitive impairment. CPAP and bilevel therapies remain foundational, but new research is exploring alternative treatments like hypoglossal nerve stimulation and positional therapies. With wearable sleep diagnostics and remote polysomnography gaining traction, personalized care is increasingly achievable. Sleep Medicine & Breathing Disorders is also contributing to public health policy by linking sleep-related breathing issues to occupational performance, road safety, and mental well-being. Emerging tools like machine learning for apnea detection and circadian rhythm profiling offer new frontiers for individualized intervention. Clinicians are now urged to adopt a multidisciplinary lens, integrating pulmonology, neurology, and behavioral medicine in sleep health management.
Title : Global warming and increasing respiratory illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title :
Saurabh Chattopadhyay, University of Kentucky, United States
Title : Risk factors for mycobacterium avium complex infections in patients with chronic obstructive pulmonary disease
Alizaman Sadigov, Medical University, United States
Title : Managing integration and interoperability in transformed pulmonology, respiratory medicine and lung health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Oncology (PPO) to be set up via precision oncology strategy for cancer care team: Developing targeted lung cancer therapy and advancing personalized cancer care
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Advancements in pulmonology and respiratory care through the view of Personalized and Precision Medicine (PPM) and biodesign-driven translational applications
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation